Underwriting AgreementUnderwriting Agreement • July 28th, 2009 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Cell Therapeutics, Inc., a Washington corporation (“Company”), confirms its agreement, subject to the terms and conditions stated herein, to issue and sell to Rodman & Renshaw, LLC (the “Underwriter”) an aggregate of 29,332,107 shares (the “Firm Shares”) of Common Stock, no par value per share (the “Common Stock”), and warrants (the “Firm Warrants” and together with the Firm Shares, the “Firm Securities”) to purchase an aggregate of 7,333,027 shares of Common Stock (the “Firm Warrant Shares”). The Firm Securities and the Optional Securities that the Underwriter elects to purchase pursuant to Section 2 are herein collectively referred to as the “Securities.”
